These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 33216758)

  • 21. A novel FK-506-binding-like protein that lacks peptidyl-prolyl isomerase activity is involved in intracellular infection and in vivo virulence of Burkholderia pseudomallei.
    Norville IH; Breitbach K; Eske-Pogodda K; Harmer NJ; Sarkar-Tyson M; Titball RW; Steinmetz I
    Microbiology (Reading); 2011 Sep; 157(Pt 9):2629-2638. PubMed ID: 21680634
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolates.
    Challacombe JF; Stubben CJ; Klimko CP; Welkos SL; Kern SJ; Bozue JA; Worsham PL; Cote CK; Wolfe DN
    PLoS One; 2014; 9(12):e115951. PubMed ID: 25536074
    [TBL] [Abstract][Full Text] [Related]  

  • 23. From crystal structure to in silico epitope discovery in the Burkholderia pseudomallei flagellar hook-associated protein FlgK.
    Gourlay LJ; Thomas RJ; Peri C; Conchillo-Solé O; Ferrer-Navarro M; Nithichanon A; Vila J; Daura X; Lertmemongkolchai G; Titball R; Colombo G; Bolognesi M
    FEBS J; 2015 Apr; 282(7):1319-33. PubMed ID: 25645451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing: comparative genomics associated with differential virulence.
    Sahl JW; Allender CJ; Colman RE; Califf KJ; Schupp JM; Currie BJ; Van Zandt KE; Gelhaus HC; Keim P; Tuanyok A
    PLoS One; 2015; 10(3):e0121052. PubMed ID: 25803742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polysaccharides and virulence of Burkholderia pseudomallei.
    Sarkar-Tyson M; Thwaite JE; Harding SV; Smither SJ; Oyston PCF; Atkins TP; Titball RW
    J Med Microbiol; 2007 Aug; 56(Pt 8):1005-1010. PubMed ID: 17644705
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peptidyl-Prolyl Isomerase
    Bzdyl NM; Scott NE; Norville IH; Scott AE; Atkins T; Pang S; Sarovich DS; Coombs G; Inglis TJJ; Kahler CM; Sarkar-Tyson M
    Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31331957
    [No Abstract]   [Full Text] [Related]  

  • 27. Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection.
    Price EP; Sarovich DS; Mayo M; Tuanyok A; Drees KP; Kaestli M; Beckstrom-Sternberg SM; Babic-Sternberg JS; Kidd TJ; Bell SC; Keim P; Pearson T; Currie BJ
    mBio; 2013 Jul; 4(4):. PubMed ID: 23860767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Enhanced intracellular survival and epithelial cell adherence abilities of Burkholderia pseudomallei morphotypes are dependent on differential expression of virulence-associated proteins during mid-logarithmic growth phase.
    Al-Maleki AR; Mariappan V; Vellasamy KM; Shankar EM; Tay ST; Vadivelu J
    J Proteomics; 2014 Jun; 106():205-20. PubMed ID: 24742602
    [TBL] [Abstract][Full Text] [Related]  

  • 29. BPSS1504, a cluster 1 type VI secretion gene, is involved in intracellular survival and virulence of Burkholderia pseudomallei.
    Hopf V; Göhler A; Eske-Pogodda K; Bast A; Steinmetz I; Breitbach K
    Infect Immun; 2014 May; 82(5):2006-15. PubMed ID: 24595140
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Variable virulence factors in Burkholderia pseudomallei (melioidosis) associated with human disease.
    Sarovich DS; Price EP; Webb JR; Ward LM; Voutsinos MY; Tuanyok A; Mayo M; Kaestli M; Currie BJ
    PLoS One; 2014; 9(3):e91682. PubMed ID: 24618705
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pathogenesis of and immunity to melioidosis.
    Brett PJ; Woods DE
    Acta Trop; 2000 Feb; 74(2-3):201-10. PubMed ID: 10674650
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Type III Secretion in the Melioidosis Pathogen
    Vander Broek CW; Stevens JM
    Front Cell Infect Microbiol; 2017; 7():255. PubMed ID: 28664152
    [No Abstract]   [Full Text] [Related]  

  • 33. Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis.
    Stevens MP; Haque A; Atkins T; Hill J; Wood MW; Easton A; Nelson M; Underwood-Fowler C; Titball RW; Bancroft GJ; Galyov EE
    Microbiology (Reading); 2004 Aug; 150(Pt 8):2669-2676. PubMed ID: 15289563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advances and remaining uncertainties in the epidemiology of Burkholderia pseudomallei and melioidosis.
    Currie BJ
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):225-7. PubMed ID: 18166205
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The serine protease inhibitor Ecotin is required for full virulence of Burkholderia pseudomallei.
    Ireland PM; Marshall L; Norville I; Sarkar-Tyson M
    Microb Pathog; 2014; 67-68():55-8. PubMed ID: 24462575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multicomponent Gold-Linked Glycoconjugate Vaccine Elicits Antigen-Specific Humoral and Mixed T
    Tapia D; Sanchez-Villamil JI; Stevenson HL; Torres AG
    mBio; 2021 Jun; 12(3):e0122721. PubMed ID: 34182777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Burkholderia pseudomallei as an Enteric Pathogen: Identification of Virulence Factors Mediating Gastrointestinal Infection.
    Sanchez-Villamil JI; Tapia D; Borlee GI; Borlee BR; Walker DH; Torres AG
    Infect Immun; 2020 Dec; 89(1):. PubMed ID: 33106293
    [No Abstract]   [Full Text] [Related]  

  • 38. A naturally derived outer-membrane vesicle vaccine protects against lethal pulmonary Burkholderia pseudomallei infection.
    Nieves W; Asakrah S; Qazi O; Brown KA; Kurtz J; Aucoin DP; McLachlan JB; Roy CJ; Morici LA
    Vaccine; 2011 Oct; 29(46):8381-9. PubMed ID: 21871517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Burkholderia pseudomallei Δasd mutant exhibits attenuated intracellular infectivity and imparts protection against acute inhalation melioidosis in mice.
    Norris MH; Propst KL; Kang Y; Dow SW; Schweizer HP; Hoang TT
    Infect Immun; 2011 Oct; 79(10):4010-8. PubMed ID: 21807903
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of the Burkholderia pseudomallei K96243 capsular polysaccharide I coding region.
    Cuccui J; Milne TS; Harmer N; George AJ; Harding SV; Dean RE; Scott AE; Sarkar-Tyson M; Wren BW; Titball RW; Prior JL
    Infect Immun; 2012 Mar; 80(3):1209-21. PubMed ID: 22252864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.